GENTAUR Molecular Products.
Monoclonal Antibody, ELISA Kit, Polyclonal Antibody, Recombinant/Purified Protein.Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery
Regulator of sigma-E protease RseP (EC 3.4.24.-) (S2P endopeptidase) (Site-2 protease RseP) (S2P protease RseP) (Site-2-type intramembrane protease)
RSEP_ECOLI Reviewed; 450 AA.
P0AEH1; P37764;
06-DEC-2005, integrated into UniProtKB/Swiss-Prot.
06-DEC-2005, sequence version 1.
28-MAR-2018, entry version 113.
RecName: Full=Regulator of sigma-E protease RseP;
EC=3.4.24.-;
AltName: Full=S2P endopeptidase;
AltName: Full=Site-2 protease RseP;
Short=S2P protease RseP;
AltName: Full=Site-2-type intramembrane protease;
Name=rseP; Synonyms=ecfE, yaeL; OrderedLocusNames=b0176, JW0171;
Escherichia coli (strain K12).
Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
Enterobacteriaceae; Escherichia.
NCBI_TaxID=83333;
[1]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], INDUCTION, AND DISRUPTION
PHENOTYPE.
PubMed=11274153; DOI=10.1074/jbc.M100464200;
Dartigalongue C., Missiakas D., Raina S.;
"Characterization of the Escherichia coli sigma E regulon.";
J. Biol. Chem. 276:20866-20875(2001).
[2]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
Takemoto K., Mori H., Murayama N., Kataoka K., Yano M., Itoh T.,
Yamamoto Y., Inokuchi H., Miki T., Hatada E., Fukuda R., Ichihara S.,
Mizuno T., Makino K., Nakata A., Yura T., Sampei G., Mizobuchi K.;
"Systematic sequencing of the Escherichia coli genome: analysis of the
4.0 - 6.0 min (189,987 - 281,416bp) region.";
Submitted (FEB-1996) to the EMBL/GenBank/DDBJ databases.
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
STRAIN=K12 / MG1655 / ATCC 47076;
Chung E., Allen E., Araujo R., Aparicio A.M., Davis K., Duncan M.,
Federspiel N., Hyman R., Kalman S., Komp C., Kurdi O., Lew H., Lin D.,
Namath A., Oefner P., Roberts D., Schramm S., Davis R.W.;
"Sequence of minutes 4-25 of Escherichia coli.";
Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
STRAIN=K12 / MG1655 / ATCC 47076;
PubMed=9278503; DOI=10.1126/science.277.5331.1453;
Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
Mau B., Shao Y.;
"The complete genome sequence of Escherichia coli K-12.";
Science 277:1453-1462(1997).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
PubMed=16738553; DOI=10.1038/msb4100049;
Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
"Highly accurate genome sequences of Escherichia coli K-12 strains
MG1655 and W3110.";
Mol. Syst. Biol. 2:E1-E5(2006).
[6]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-103.
PubMed=2995358;
Icho T., Sparrow C.P., Raetz C.R.H.;
"Molecular cloning and sequencing of the gene for CDP-diglyceride
synthetase of Escherichia coli.";
J. Biol. Chem. 260:12078-12083(1985).
[7]
IDENTIFICATION.
PubMed=7984428; DOI=10.1093/nar/22.22.4756;
Borodovsky M., Rudd K.E., Koonin E.V.;
"Intrinsic and extrinsic approaches for detecting genes in a bacterial
genome.";
Nucleic Acids Res. 22:4756-4767(1994).
[8]
SUBCELLULAR LOCATION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF HIS-22.
PubMed=11689431; DOI=10.1093/emboj/20.21.5908;
Dartigalongue C., Loferer H., Raina S.;
"EcfE, a new essential inner membrane protease: its role in the
regulation of heat shock response in Escherichia coli.";
EMBO J. 20:5908-5918(2001).
[9]
DISCUSSION OF FUNCTION, SUBCELLULAR LOCATION, TOPOLOGY, DOMAIN,
DISRUPTION PHENOTYPE, AND MUTAGENESIS OF HIS-22; GLU-23; HIS-26;
VAL-261 AND ASP-402.
STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
PubMed=11750129; DOI=10.1016/S0378-1119(01)00823-X;
Kanehara K., Akiyama Y., Ito K.;
"Characterization of the yaeL gene product and its S2P-protease motifs
in Escherichia coli.";
Gene 281:71-79(2001).
[10]
FUNCTION IN CLEAVAGE OF RSEA, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF
HIS-22 AND ASP-402.
STRAIN=K12;
PubMed=12183368; DOI=10.1101/gad.1002302;
Kanehara K., Ito K., Akiyama Y.;
"YaeL (EcfE) activates the sigma(E) pathway of stress response through
a site-2 cleavage of anti-sigma(E), RseA.";
Genes Dev. 16:2147-2155(2002).
[11]
FUNCTION IN THE CLEAVAGE OF RSEA, POSSIBLE ACTIVE SITE, DISRUPTION
PHENOTYPE, AND MUTAGENESIS OF GLU-23.
STRAIN=K12;
PubMed=12183369; DOI=10.1101/gad.1008902;
Alba B.M., Leeds J.A., Onufryk C., Lu C.Z., Gross C.A.;
"DegS and YaeL participate sequentially in the cleavage of RseA to
activate the sigma(E)-dependent extracytoplasmic stress response.";
Genes Dev. 16:2156-2168(2002).
[12]
SUBCELLULAR LOCATION.
STRAIN=K12 / JM109 / ATCC 53323;
PubMed=11867724; DOI=10.1073/pnas.052018199;
Drew D., Sjoestrand D., Nilsson J., Urbig T., Chin C.-N.,
de Gier J.-W., von Heijne G.;
"Rapid topology mapping of Escherichia coli inner-membrane proteins by
prediction and PhoA/GFP fusion analysis.";
Proc. Natl. Acad. Sci. U.S.A. 99:2690-2695(2002).
[13]
INTERACTION WITH RSEA, DOMAIN, AND MUTAGENESIS OF GLY-214;
234-ALA-ALA-235; GLY-243; ASP-244 AND ILE-246.
STRAIN=K12 / AD16;
PubMed=14633997; DOI=10.1093/emboj/cdg602;
Kanehara K., Ito K., Akiyama Y.;
"YaeL proteolysis of RseA is controlled by the PDZ domain of YaeL and
a Gln-rich region of RseA.";
EMBO J. 22:6389-6398(2003).
[14]
FUNCTION IN THE CLEAVAGE OF RSEA, AND MUTAGENESIS OF HIS-22.
PubMed=15496982; DOI=10.1038/sj.emboj.7600449;
Akiyama Y., Kanehara K., Ito K.;
"RseP (YaeL), an Escherichia coli RIP protease, cleaves transmembrane
sequences.";
EMBO J. 23:4434-4442(2004).
[15]
SUBCELLULAR LOCATION.
STRAIN=K12 / MG1655 / ATCC 47076;
PubMed=15919996; DOI=10.1126/science.1109730;
Daley D.O., Rapp M., Granseth E., Melen K., Drew D., von Heijne G.;
"Global topology analysis of the Escherichia coli inner membrane
proteome.";
Science 308:1321-1323(2005).
[16]
FUNCTION IN CLEAVAGE OF RSEA, INTERACTION WITH RSEA, SUBSTRATE
RECOGNITION, AND MUTAGENESIS OF HIS-22; GLU-23; ASN-389; ASN-394;
PRO-397 AND PRO-399.
STRAIN=K12 / AD16;
PubMed=18268014; DOI=10.1074/jbc.M709984200;
Koide K., Ito K., Akiyama Y.;
"Substrate recognition and binding by RseP, an Escherichia coli
intramembrane protease.";
J. Biol. Chem. 283:9562-9570(2008).
[17]
FUNCTION IN CLEAVAGE OF SIGNAL PEPTIDES, ENZYME REGULATION, AND
MUTAGENESIS OF HIS-22.
STRAIN=K12;
PubMed=21810987; DOI=10.1073/pnas.1108376108;
Saito A., Hizukuri Y., Matsuo E., Chiba S., Mori H., Nishimura O.,
Ito K., Akiyama Y.;
"Post-liberation cleavage of signal peptides is catalyzed by the site-
2 protease (S2P) in bacteria.";
Proc. Natl. Acad. Sci. U.S.A. 108:13740-13745(2011).
[18]
DOMAIN, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF ILE-215 AND ILE-304.
STRAIN=K12;
PubMed=23016873; DOI=10.1111/mmi.12053;
Hizukuri Y., Akiyama Y.;
"PDZ domains of RseP are not essential for sequential cleavage of RseA
or stress-induced sigma(E) activation in vivo.";
Mol. Microbiol. 86:1232-1245(2012).
[19]
X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 127-221, X-RAY
CRYSTALLOGRAPHY (0.98 ANGSTROMS) OF 222-309, FUNCTION IN CLEAVAGE OF
RSEA, DOMAIN, AND MUTAGENESIS OF ALA-115; ILE-145; LEU-151; TRP-162;
LEU-169; LEU-213 AND GLY-214.
STRAIN=K12;
PubMed=18945679; DOI=10.1074/jbc.M806603200;
Inaba K., Suzuki M., Maegawa K., Akiyama S., Ito K., Akiyama Y.;
"A pair of circularly permutated PDZ domains control RseP, the S2P
family intramembrane protease of Escherichia coli.";
J. Biol. Chem. 283:35042-35052(2008).
[20]
X-RAY CRYSTALLOGRAPHY (1.67 ANGSTROMS) OF 127-220, X-RAY
CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 222-307, DOMAIN, AND MUTAGENESIS
OF ILE-215 AND ILE-304.
PubMed=19706448; DOI=10.1073/pnas.0903289106;
Li X., Wang B., Feng L., Kang H., Qi Y., Wang J., Shi Y.;
"Cleavage of RseA by RseP requires a carboxyl-terminal hydrophobic
amino acid following DegS cleavage.";
Proc. Natl. Acad. Sci. U.S.A. 106:14837-14842(2009).
-!- FUNCTION: A site-2 regulated intramembrane protease (S2P) that
cleaves the peptide bond between 'Ala-108' and 'Cys-109' in the
transmembrane region of RseA. Part of a regulated intramembrane
proteolysis (RIP) cascade. Acts on DegS-cleaved RseA to release
the cytoplasmic domain of RseA, residue "Val-148" of RseA may be
required for this. This provides the cell with sigma-E (RpoE)
activity through the proteolysis of RseA. Can also cleave
sequences in transmembrane regions of other proteins (such as
LacY) as well as liberated signal peptides of beta-lactamase,
OmpF, LivK, SecM, PhoA, LivJ, OmpC, Lpp and TorA, probably within
the membrane. {ECO:0000269|PubMed:12183368,
ECO:0000269|PubMed:12183369, ECO:0000269|PubMed:15496982,
ECO:0000269|PubMed:18268014, ECO:0000269|PubMed:18945679,
ECO:0000269|PubMed:21810987}.
-!- COFACTOR:
Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000305};
-!- ENZYME REGULATION: Inhibited by Zn(2+) chelator 1,10-
phenanthroline. {ECO:0000269|PubMed:21810987}.
-!- SUBUNIT: Interacts with RseA; the third transmembrane domain can
be cross-linked to the transmembrane domain of RseA.
{ECO:0000269|PubMed:14633997, ECO:0000269|PubMed:18268014}.
-!- SUBCELLULAR LOCATION: Cell inner membrane
{ECO:0000269|PubMed:11689431, ECO:0000269|PubMed:11750129,
ECO:0000269|PubMed:11867724, ECO:0000269|PubMed:15919996}; Multi-
pass membrane protein {ECO:0000269|PubMed:11689431,
ECO:0000269|PubMed:11750129, ECO:0000269|PubMed:11867724,
ECO:0000269|PubMed:15919996}.
-!- INDUCTION: Part of the sigma-E regulon. Also has a primary sigma-
70 factor promoter. {ECO:0000269|PubMed:11274153}.
-!- DOMAIN: The 2 circularly premutated PDZ domains act to negatively
regulate protease action on intact RseA; mutations in PDZ 1 (PDZ-
N) have a more deleterious effect than similar mutations in PDZ 2
(PDZ-C). A 31 residue insertion in PDZ-C (between Val-261 and Met-
262) domain inhibits protease activity, whereas deletion of
residues 203-279 alleviates the PDZ-inhibition, allowing cleavage
of intact RseA. {ECO:0000269|PubMed:11750129,
ECO:0000269|PubMed:14633997, ECO:0000269|PubMed:18945679,
ECO:0000269|PubMed:19706448, ECO:0000269|PubMed:23016873}.
-!- DISRUPTION PHENOTYPE: Essential. Depletion experiments lead to
cessation of growth, elongated cells and limited lysis, as well as
decreased amounts of sigma-E. Not essential in an rseA deletion
strain, when sigma-E is overexpressed or in ompA-ompC deletion
strain. In the latter has severely decreased growth at 20 degrees
Celsius. Accumulation of an RseA proteolysis intermediate.
{ECO:0000269|PubMed:11274153, ECO:0000269|PubMed:11689431,
ECO:0000269|PubMed:11750129, ECO:0000269|PubMed:12183368,
ECO:0000269|PubMed:12183369, ECO:0000269|PubMed:23016873}.
-!- MISCELLANEOUS: Regulated intramembrane proteolysis (RIP) occurs
when an extracytoplasmic signal triggers a concerted proteolytic
cascade to transmit information and elicit cellular responses. A
membrane-spanning regulatory substrate protein is first cut
extracytoplasmically (site-1 protease, S1P), then within the
membrane itself (site-2 protease, S2P, this enzyme), while
cytoplasmic proteases finish degrading the regulatory protein,
liberating the effector protein.
-!- SIMILARITY: Belongs to the peptidase M50B family. {ECO:0000305}.
-!- CAUTION: Was originally thought to be a negative regulator of
sigma-E function and to act directly on sigma-E and RpoH; this may
not be physiologically relevant. {ECO:0000305|PubMed:11689431}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; AF407012; AAL01378.1; -; Genomic_DNA.
EMBL; U70214; AAB08605.1; -; Genomic_DNA.
EMBL; U00096; AAC73287.1; -; Genomic_DNA.
EMBL; AP009048; BAA77851.1; -; Genomic_DNA.
EMBL; M11330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
PIR; H64741; H64741.
RefSeq; NP_414718.1; NC_000913.3.
RefSeq; WP_001295561.1; NZ_LN832404.1.
PDB; 2ZPL; X-ray; 1.70 A; A/B/C=127-221.
PDB; 2ZPM; X-ray; 0.98 A; A=222-309.
PDB; 3ID1; X-ray; 1.67 A; A=127-220.
PDB; 3ID2; X-ray; 3.09 A; A/B=222-309.
PDB; 3ID3; X-ray; 2.01 A; A/B=222-309.
PDB; 3ID4; X-ray; 1.60 A; A=222-307.
PDBsum; 2ZPL; -.
PDBsum; 2ZPM; -.
PDBsum; 3ID1; -.
PDBsum; 3ID2; -.
PDBsum; 3ID3; -.
PDBsum; 3ID4; -.
ProteinModelPortal; P0AEH1; -.
SMR; P0AEH1; -.
BioGrid; 4261736; 104.
DIP; DIP-48061N; -.
IntAct; P0AEH1; 2.
STRING; 316385.ECDH10B_0156; -.
MEROPS; M50.004; -.
EPD; P0AEH1; -.
PaxDb; P0AEH1; -.
PRIDE; P0AEH1; -.
EnsemblBacteria; AAC73287; AAC73287; b0176.
EnsemblBacteria; BAA77851; BAA77851; BAA77851.
GeneID; 944871; -.
KEGG; ecj:JW0171; -.
KEGG; eco:b0176; -.
PATRIC; fig|1411691.4.peg.2103; -.
EchoBASE; EB2331; -.
EcoGene; EG12436; rseP.
eggNOG; ENOG4105DZP; Bacteria.
eggNOG; COG0750; LUCA.
HOGENOM; HOG000006281; -.
InParanoid; P0AEH1; -.
KO; K11749; -.
OMA; MFLGLFN; -.
PhylomeDB; P0AEH1; -.
BioCyc; EcoCyc:EG12436-MONOMER; -.
BioCyc; MetaCyc:EG12436-MONOMER; -.
EvolutionaryTrace; P0AEH1; -.
PRO; PR:P0AEH1; -.
Proteomes; UP000000318; Chromosome.
Proteomes; UP000000625; Chromosome.
GO; GO:0005887; C:integral component of plasma membrane; IDA:EcoliWiki.
GO; GO:0005886; C:plasma membrane; IDA:EcoCyc.
GO; GO:0043856; F:anti-sigma factor antagonist activity; IMP:EcoCyc.
GO; GO:0045152; F:antisigma factor binding; IDA:EcoCyc.
GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
GO; GO:0004222; F:metalloendopeptidase activity; IDA:EcoCyc.
InterPro; IPR001478; PDZ.
InterPro; IPR036034; PDZ_sf.
InterPro; IPR004387; Pept_M50_Zn.
InterPro; IPR008915; Peptidase_M50.
Pfam; PF00595; PDZ; 1.
Pfam; PF02163; Peptidase_M50; 1.
SMART; SM00228; PDZ; 2.
SUPFAM; SSF50156; SSF50156; 2.
TIGRFAMs; TIGR00054; TIGR00054; 1.
PROSITE; PS50106; PDZ; 1.
PROSITE; PS00142; ZINC_PROTEASE; 1.
1: Evidence at protein level;
3D-structure; Cell inner membrane; Cell membrane; Complete proteome;
Hydrolase; Membrane; Metal-binding; Metalloprotease; Protease;
Reference proteome; Repeat; Transmembrane; Transmembrane helix; Zinc.
CHAIN 1 450 Regulator of sigma-E protease RseP.
/FTId=PRO_0000088417.
TRANSMEM 1 21 Helical. {ECO:0000255}.
TOPO_DOM 22 103 Periplasmic.
{ECO:0000305|PubMed:11750129}.
TRANSMEM 104 124 Helical. {ECO:0000255}.
TOPO_DOM 125 375 Cytoplasmic.
{ECO:0000305|PubMed:11750129}.
TRANSMEM 376 396 Helical. {ECO:0000255}.
TOPO_DOM 397 429 Periplasmic.
{ECO:0000305|PubMed:11750129}.
TRANSMEM 430 450 Helical. {ECO:0000255}.
DOMAIN 127 220 PDZ 1. {ECO:0000255|PROSITE-
ProRule:PRU00143}.
DOMAIN 222 309 PDZ 2. {ECO:0000255|PROSITE-
ProRule:PRU00143}.
ACT_SITE 23 23 {ECO:0000305}.
METAL 22 22 Zinc; catalytic. {ECO:0000305}.
METAL 26 26 Zinc; catalytic. {ECO:0000255|PROSITE-
ProRule:PRU10095}.
MUTAGEN 22 22 H->A: Loss of protease activity.
{ECO:0000269|PubMed:11689431,
ECO:0000269|PubMed:11750129,
ECO:0000269|PubMed:12183368,
ECO:0000269|PubMed:15496982,
ECO:0000269|PubMed:18268014,
ECO:0000269|PubMed:21810987}.
MUTAGEN 22 22 H->F: Loss of protease activity of RseA
and signal peptides, does not complement
deletion mutant. Binds substrate.
{ECO:0000269|PubMed:11689431,
ECO:0000269|PubMed:11750129,
ECO:0000269|PubMed:12183368,
ECO:0000269|PubMed:15496982,
ECO:0000269|PubMed:18268014,
ECO:0000269|PubMed:21810987}.
MUTAGEN 23 23 E->A: Low basal sigma-E activity, sigma-E
not induced. No proteolysis of RseA.
{ECO:0000269|PubMed:11750129,
ECO:0000269|PubMed:12183369,
ECO:0000269|PubMed:18268014}.
MUTAGEN 23 23 E->D: Behaves like wild-type in vivo,
slight reduction in RseA cleavage in
vitro. {ECO:0000269|PubMed:11750129,
ECO:0000269|PubMed:12183369,
ECO:0000269|PubMed:18268014}.
MUTAGEN 23 23 E->Q: Does not complement deletion
mutant. {ECO:0000269|PubMed:11750129,
ECO:0000269|PubMed:12183369,
ECO:0000269|PubMed:18268014}.
MUTAGEN 23 23 E->S: Loss of protease activity.
{ECO:0000269|PubMed:11750129,
ECO:0000269|PubMed:12183369,
ECO:0000269|PubMed:18268014}.
MUTAGEN 26 26 H->F: Does not complement deletion
mutant. {ECO:0000269|PubMed:11750129}.
MUTAGEN 115 115 A->V: No effect. Cleaves RseA without
previous DegS cleavage; when associated
with R-214.
{ECO:0000269|PubMed:18945679}.
MUTAGEN 145 145 I->N: Cuts RseA without previous DegS
cleavage. {ECO:0000269|PubMed:18945679}.
MUTAGEN 151 151 L->P: Cuts RseA without previous DegS
cleavage. {ECO:0000269|PubMed:18945679}.
MUTAGEN 162 162 W->R: Cuts RseA without previous DegS
cleavage. {ECO:0000269|PubMed:18945679}.
MUTAGEN 169 169 L->S: Cuts RseA without previous DegS
cleavage. {ECO:0000269|PubMed:18945679}.
MUTAGEN 213 213 L->P: Cuts RseA without previous DegS
cleavage. {ECO:0000269|PubMed:18945679}.
MUTAGEN 214 214 G->E,Q: Cuts RseA without previous DegS
cleavage. {ECO:0000269|PubMed:14633997,
ECO:0000269|PubMed:18945679}.
MUTAGEN 214 214 G->R: Weakly cuts RseA without previous
DegS cleavage. Stronger cleavage; when
associated with V-115.
{ECO:0000269|PubMed:14633997,
ECO:0000269|PubMed:18945679}.
MUTAGEN 215 215 I->A: No cleavage of RseA in vitro
(PubMed:19706448), cleavage of RseA
(PubMed:23016873) in vivo.
{ECO:0000269|PubMed:19706448,
ECO:0000269|PubMed:23016873}.
MUTAGEN 234 235 AA->KK: Cuts RseA without previous DegS
cleavage. {ECO:0000269|PubMed:14633997}.
MUTAGEN 243 243 G->Q: Cuts RseA without previous DegS
cleavage. {ECO:0000269|PubMed:14633997}.
MUTAGEN 244 244 D->K: Cuts RseA without previous DegS
cleavage. {ECO:0000269|PubMed:14633997}.
MUTAGEN 246 246 I->Y: Cuts RseA without previous DegS
cleavage. {ECO:0000269|PubMed:14633997}.
MUTAGEN 261 261 V->VTDSYTQVASWTEPFPFSIQGDPRSDQETAFV: Does
not complement deletion mutant.
{ECO:0000269|PubMed:11750129}.
MUTAGEN 304 304 I->A: No cleavage of RseA in vitro
(PubMed:19706448), cleavage of RseA
(PubMed:23016873) in vivo.
{ECO:0000269|PubMed:19706448,
ECO:0000269|PubMed:23016873}.
MUTAGEN 389 389 N->C,G,L: Decreased substrate binding,
retains some proteolytic activity.
{ECO:0000269|PubMed:18268014}.
MUTAGEN 389 389 N->Q: No effect.
{ECO:0000269|PubMed:18268014}.
MUTAGEN 394 394 N->C: Decreased substrate binding,
retains some proteolytic activity.
{ECO:0000269|PubMed:18268014}.
MUTAGEN 397 397 P->C: Decreased substrate binding,
retains some proteolytic activity.
{ECO:0000269|PubMed:18268014}.
MUTAGEN 399 399 P->C: Decreased substrate binding,
retains some proteolytic activity.
{ECO:0000269|PubMed:18268014}.
MUTAGEN 402 402 D->N: Does not complement deletion
mutant, loss of protease activity.
{ECO:0000269|PubMed:11750129,
ECO:0000269|PubMed:12183368}.
STRAND 130 134 {ECO:0000244|PDB:3ID1}.
HELIX 139 142 {ECO:0000244|PDB:3ID1}.
STRAND 150 154 {ECO:0000244|PDB:3ID1}.
HELIX 162 171 {ECO:0000244|PDB:3ID1}.
TURN 172 174 {ECO:0000244|PDB:3ID1}.
STRAND 176 183 {ECO:0000244|PDB:3ID1}.
STRAND 191 196 {ECO:0000244|PDB:3ID1}.
TURN 204 206 {ECO:0000244|PDB:3ID1}.
HELIX 209 212 {ECO:0000244|PDB:3ID1}.
STRAND 215 217 {ECO:0000244|PDB:3ID1}.
STRAND 227 229 {ECO:0000244|PDB:2ZPM}.
STRAND 231 233 {ECO:0000244|PDB:3ID2}.
TURN 234 236 {ECO:0000244|PDB:2ZPM}.
STRAND 245 249 {ECO:0000244|PDB:2ZPM}.
HELIX 257 266 {ECO:0000244|PDB:2ZPM}.
STRAND 272 278 {ECO:0000244|PDB:2ZPM}.
STRAND 281 287 {ECO:0000244|PDB:2ZPM}.
STRAND 290 292 {ECO:0000244|PDB:2ZPM}.
STRAND 295 297 {ECO:0000244|PDB:3ID4}.
STRAND 299 301 {ECO:0000244|PDB:2ZPM}.
STRAND 304 307 {ECO:0000244|PDB:3ID4}.
SEQUENCE 450 AA; 49071 MW; 81A93BC113FBB66C CRC64;
MLSFLWDLAS FIVALGVLIT VHEFGHFWVA RRCGVRVERF SIGFGKALWR RTDKLGTEYV
IALIPLGGYV KMLDERAEPV VPELRHHAFN NKSVGQRAAI IAAGPVANFI FAIFAYWLVF
IIGVPGVRPV VGEIAANSIA AEAQIAPGTE LKAVDGIETP DWDAVRLQLV DKIGDESTTI
TVAPFGSDQR RDVKLDLRHW AFEPDKEDPV SSLGIRPRGP QIEPVLENVQ PNSAASKAGL
QAGDRIVKVD GQPLTQWVTF VMLVRDNPGK SLALEIERQG SPLSLTLIPE SKPGNGKAIG
FVGIEPKVIP LPDEYKVVRQ YGPFNAIVEA TDKTWQLMKL TVSMLGKLIT GDVKLNNLSG
PISIAKGAGM TAELGVVYYL PFLALISVNL GIINLFPLPV LDGGHLLFLA IEKIKGGPVS
ERVQDFCYRI GSILLVLLMG LALFNDFSRL
Related products :
GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
Fax 0032 16 50 90 45
info@gentaur.com | Gentaur
GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur
GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50
Fax 01 43 25 01 60
RCS Paris B 484 237 888
SIRET 48423788800017
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
france@gentaur.com | Gentaur
GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur
GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel: 0208-080893 Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62 SWIFT RABONL2U
GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur
ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX 058 710 33 48
poland@gentaur.com | Gentaur
Other countries
Österreich +43720880899
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Danmark +4569918806
Finland Helsset +358942419041
Magyarország Budapest +3619980547
Ireland Dublin+35316526556
Luxembourg+35220880274
Norge Oslo+4721031366
Sverige Stockholm+46852503438
Schweiz Züri+41435006251
US New York+17185132983
GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo
Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur
Pathways :
WP470: Proteasome Degradation
WP2199: Seed Development
WP1017: Type II interferon signaling (IFNG)
WP1136: Type II interferon signaling (IFNG)
WP1253: Type II interferon signaling (IFNG)
WP1289: Type II interferon signaling (IFNG)
WP1350: Type II interferon signaling (IFNG)
WP1584: Type II diabetes mellitus
WP1689: Porphyrin and chlorophyll metabolism
WP2113: Type III interferon signaling
WP2272: Pathogenic Escherichia coli infection
WP585: Interferon type I
WP619: Type II interferon signaling (IFNG)
WP654: ATM
WP786: Type II interferon signaling (IFNG)
WP900: Type II interferon signaling (IFNG)
Related Genes :
[Clca4a Clca6] Calcium-activated chloride channel regulator 4A (EC 3.4.-.-) (Calcium-activated chloride channel regulator 6) (mClca6) [Cleaved into: Calcium-activated chloride channel regulator 4A, 110 kDa form; Calcium-activated chloride channel regulator 4A, 30 kDa form]
[CFLAR CASH CASP8AP1 CLARP MRIT] CASP8 and FADD-like apoptosis regulator (Caspase homolog) (CASH) (Caspase-eight-related protein) (Casper) (Caspase-like apoptosis regulatory protein) (CLARP) (Cellular FLICE-like inhibitory protein) (c-FLIP) (FADD-like antiapoptotic molecule 1) (FLAME-1) (Inhibitor of FLICE) (I-FLICE) (MACH-related inducer of toxicity) (MRIT) (Usurpin) [Cleaved into: CASP8 and FADD-like apoptosis regulator subunit p43; CASP8 and FADD-like apoptosis regulator subunit p12]
[CLCA2 CACC3] Calcium-activated chloride channel regulator 2 (EC 3.4.-.-) (Calcium-activated chloride channel family member 2) (hCLCA2) (Calcium-activated chloride channel protein 3) (CaCC-3) (hCaCC-3) [Cleaved into: Calcium-activated chloride channel regulator 2, 109 kDa form; Calcium-activated chloride channel regulator 2, 35 kDa form]
[Cflar Cash] CASP8 and FADD-like apoptosis regulator (Caspase homolog) (CASH) (Caspase-eight-related protein) (Casper) (Caspase-like apoptosis regulatory protein) (CLARP) (Cellular FLICE-like inhibitory protein) (c-FLIP) (FADD-like antiapoptotic molecule 1) (FLAME-1) (Inhibitor of FLICE) (I-FLICE) (MACH-related inducer of toxicity) (MRIT) (Usurpin) [Cleaved into: CASP8 and FADD-like apoptosis regulator subunit p43; CASP8 and FADD-like apoptosis regulator subunit p12]
[CLCA4 CaCC2 UNQ562/PRO1124] Calcium-activated chloride channel regulator 4 (EC 3.4.-.-) (Calcium-activated chloride channel family member 4) (hCLCA4) (Calcium-activated chloride channel protein 2) (CaCC-2) (hCaCC-2) (Chloride channel accessory 4) [Cleaved into: Calcium-activated chloride channel regulator 4, 110 kDa form; Calcium-activated chloride channel regulator 4, 30 kDa form]
[ARR4 ATRR1 IBC7 At1g10470 T10O24.8] Two-component response regulator ARR4 (Response regulator 1)
[UME6 CAR80 CARGR1 NIM2 RIM16 YDR207C YD8142.04C] Transcriptional regulatory protein UME6 (Negative transcriptional regulator of IME2) (Regulator of inducer of meiosis protein 16) (Unscheduled meiotic gene expression protein 6)
[APRR1 AIP1 TOC1 At5g61380 MFB13.16] Two-component response regulator-like APRR1 (ABI3-interacting protein 1) (Pseudo-response regulator 1) (Timing of CAB expression 1)
[RGS20 RGSZ1 ZGAP1] Regulator of G-protein signaling 20 (RGS20) (Gz-selective GTPase-activating protein) (G(z)GAP) (Gz-GAP) (Regulator of G-protein signaling Z1) (Regulator of Gz-selective protein signaling 1)
[MCUR1 C6orf79 CCDC90A] Mitochondrial calcium uniporter regulator 1 (MCU regulator 1) (Coiled-coil domain-containing protein 90A, mitochondrial)
[mprA Rv0981] Response regulator MprA (Mycobacterial persistence regulator A)
[csrA rsmA PA0905] Translational regulator CsrA (Carbon storage regulator) (Global translational regulatory protein RsmA)
[csrA zfiA b2696 JW2666] Carbon storage regulator (Translational dual regulator CsrA)
[CFTR ABCC7] Cystic fibrosis transmembrane conductance regulator (CFTR) (ATP-binding cassette sub-family C member 7) (Channel conductance-controlling ATPase) (EC 3.6.3.49) (cAMP-dependent chloride channel)
[CYREN C7orf49 MRI] Cell cycle regulator of non-homologous end joining (Cell cycle regulator of NHEJ) (Modulator of retrovirus infection homolog)
[CCAR2 DBC1 KIAA1967] Cell cycle and apoptosis regulator protein 2 (Cell division cycle and apoptosis regulator protein 2) (DBIRD complex subunit KIAA1967) (Deleted in breast cancer gene 1 protein) (DBC-1) (DBC.1) (NET35) (p30 DBC)
[APRR7 At5g02810 F9G14_120] Two-component response regulator-like APRR7 (Pseudo-response regulator 7)
[cueR copR ybbI b0487 JW0476] HTH-type transcriptional regulator CueR (Copper efflux regulator) (Copper export regulator)
[AIRE APECED] Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein) (APECED protein)
[nadR nadI b4390 JW5800] Trifunctional NAD biosynthesis/regulator protein NadR [Includes: Transcriptional regulator NadR; Nicotinamide mononucleotide adenylyltransferase (NMN adenylyltransferase) (NMN-AT) (NMNAT) (EC 2.7.7.1) (Nicotinamide ribonucleotide adenylyltransferase) (Nicotinamide-nucleotide adenylyltransferase); Ribosylnicotinamide kinase (RNK) (EC 2.7.1.22) (Nicotinamide riboside kinase) (NRK) (NmR-K)]
[nadR nadI pnuA STM4580] Trifunctional NAD biosynthesis/regulator protein NadR [Includes: Transcriptional regulator NadR; Nicotinamide mononucleotide adenylyltransferase (NMN adenylyltransferase) (NMN-AT) (NMNAT) (EC 2.7.7.1) (Nicotinamide ribonucleotide adenylyltransferase) (Nicotinamide-nucleotide adenylyltransferase); Ribosylnicotinamide kinase (RNK) (EC 2.7.1.22) (Nicotinamide riboside kinase) (NRK) (NmR-K)]
[RGS16 RGSR] Regulator of G-protein signaling 16 (RGS16) (A28-RGS14P) (Retinal-specific RGS) (RGS-r) (hRGS-r) (Retinally abundant regulator of G-protein signaling)
[sarR SAOUHSC_02566] HTH-type transcriptional regulator SarR (Staphylococcal accessory regulator R)
[sarA MW0580] Transcriptional regulator SarA (Staphylococcal accessory regulator A)
[rssB hnr sprE ychL b1235 JW1223] Regulator of RpoS
[Aire] Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein homolog) (APECED protein homolog)
[whiD wblB whiB3 SCO4767] Transcriptional regulator WhiD (Transcriptional regulator WhiB3)
[Cftr Abcc7] Cystic fibrosis transmembrane conductance regulator (CFTR) (ATP-binding cassette sub-family C member 7) (Channel conductance-controlling ATPase) (EC 3.6.3.49) (cAMP-dependent chloride channel)
[ARR2 ARP5 At4g16110 dl4095w FCAALL.297] Two-component response regulator ARR2 (Receiver-like protein 5)
[ATRX RAD54L XH2] Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP) (Znf-HX)
Bibliography :
No related Items
Enter catalog number :
Favorites Pages:
No Favorits